“Expression of Glioblastoma Molecular Markers and Sensitivity to Innate Immune Peptides LL-37 and Protegrin-1 As Predictors of Chemotherapy Response”. London Journal of Medical and Health Research, vol. 26, no. 2, Feb. 2026, pp. 15-25, https://journalspress.uk/index.php/LJMHR/article/view/1776.